Donate For Public and Patients Store Search

C006 - Pediatric Dermatology

Friday, March 1; 9:00 AM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • 1. Diagnose skin conditions that occur in newborn and pediatric patients more effectively.
  • 2. Select the most appropriate management strategies for children with skin disease.

Description

Aimed at general dermatologists, pediatric dermatologists, and dermatology residents, this course is intended to provide the attendee with updates on a broad range of dermatologic conditions in the neonatal and pediatric age groups. Topics covered will include neonatal dermatology, birthmarks, autoimmune conditions, inflammatory conditions, infectious diseases, and conditions of the hair and scalp. Special considerations when performing procedures and prescribing systemic medications in the pediatric patient will also be discussed.

Disclosures

  • Haggstrom, Anita N., MD: no financial relationships exist with commercial interests.
  • Irfan, Mahwish, MD: no financial relationships exist with commercial interests.
  • Lee, Grace Liao, MD: no financial relationships exist with commercial interests.
  • Maguiness, Sheilagh M., MD: Regeneron Pharmaceuticals, Inc. – A(H);
  • Mathes, Erin F., MD: Pierre Fabre Dermatologie – I(H); Rodan and Fields – SP(H); Zosano Pharma – C(H);
  • Mosser, Joy L., MD: no financial relationships exist with commercial interests.
  • Price, Harper, MD: AbbVie – I(Grants/Research Funding); Castle Creek Pharmaceuticals – I(Grants/Research Funding); Celgene – I(Grants/Research Funding); Regeneron – I(Grants/Research Funding); Sanofi – I(Grants/Research Funding); Scioderm – I(Grants/Research Funding);
  • Reichert, Barbara, MD: no financial relationships exist with commercial interests.
  • Taylor, Susan C., MD: Aclaris Therapeutics, Inc. – A(H), I(Grants/Research Funding), SP(H); Allergan, Inc – A(H), Speaker/Faculty Education(NC); Almirall – A(H); Avon Products, Inc. – C(H); Beiersdorf, Inc. – A(H), C(H), Speaker/Faculty Education(H); Boots – A(H); CannTec – B(H); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Eli Lilly and Company – I(Grants/Research Funding); Galderma Laboratories, L.P. – A(H); Galderma Laboratories, LP – Speaker/Faculty Education(H); Johnson & Johnson Consumer Products Company – A(H); KGL Skin Study Center – Independent Contractor(S); Neostrata – C(H); Unilever – SP(H);
  • Tollefson, Megha M., MD: no financial relationships exist with commercial interests.
  • Treat, James R., MD: Procter & Gamble Company – C(S);
  • Witman, Patricia M., MD: no financial relationships exist with commercial interests.
Schedule
Friday, March 1
9:00 AM
Dr. Haggstrom / Hemangiomas
9:30 AM
Dr. Witman / Not Everything Red is a Hemangioma
10:00 AM
Dr. Price / Congenital Nevi
10:30 AM
Dr. Tollefson / Morphea
11:00 AM
Dr. Maguiness / Update on Atopic Dermatitis
11:30 AM
Dr. Treat / Contact Dermatitis
12:00 PM
/ Break for lunch
1:00 PM
Dr. Taylor / Ethnic Hair and Scalp
1:30 PM
Dr. Mathes / Re-emergence of "Old" Viruses
2:00 PM
Dr. Mosser / Mastocytosis
2:30 PM
Dr. Irfan / Managing Pediatric Psoriasis: Big Drugs In Little People
3:00 PM
Dr. Reichert / You Are What you Eat, But Does It Matter For Your Skin?
3:30 PM
Dr. Lee / Lessons Learned on the Hospital Consult Service at Texas Children's Hospital
Event Details
  • Date
    Friday, March 1
  • Time
    9:00 AM - 4:00 PM
  • Location
    Room 207A
  • CME Credits
    6.00
  • Type
    Ticketed
Directors/Co-Directors
  • Patricia M. Witman, MD, FAAD
Speakers
  • Anita N. Haggstrom, MD, FAAD
  • Barbara Reichert, MD - Handout
  • Erin F. Mathes, MD, FAAD
  • Grace Liao Lee, MD, FAAD
  • Harper Price, MD, FAAD
  • James R. Treat, MD, FAAD - Handout
  • Joy L. Mosser, MD, FAAD - Handout
  • Mahwish Irfan, MD, FAAD
  • Megha M. Tollefson, MD, FAAD - Handout
  • Sheilagh M. Maguiness, MD, FAAD
  • Susan C. Taylor, MD, FAAD